Question from Deputy Ken O’Flynn - PQ 32772-26
Deputy O'Flynn asked about the number of patients eligible for treatment with omaveloxolone for Friedreich’s ataxia. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about the number of patients eligible for treatment with omaveloxolone for Friedreich’s ataxia. Read the HSE response.
Deputy O'Flynn asked about incidents recorded within the National Incident Management System (NIMS). Read the HSE response.
Deputy O'Flynn asked about the criteria being used to determine "organisational readiness" for transfer to the National Children's Hospital.
Deputy O'Flynn asked if the conversion of agency staff to direct employment has resulted in an increase in frontline staffing capacity. Read the HSE response.
Deputy O'Flynn asked if the agency premium is incorporated into workforce planning, budget allocations, or recruitment strategy. Read the HSE response.
Deputy O'Donoghue asked about improving infrastructure, patient space and family facilities in Rotunda Hospital. Read the HSE response.
Deputy O'Flynn asked has the agency conversion framework been reviewed. Read the HSE response.
Deputy Boyd Barrett asked about the protections that exist for home care staff in HSE-funded services. Read the HSE response.
Deputy Boyd Barrett asked about the auditing of allocated homecare hours that is delivered by private home-care companies. Read the HSE response.
Deputy Boyd Barrett asked whether the management teams of private homecare providers receive commission for taking on HSE-funded clients. Read the HSE response.